{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:31:47Z","timestamp":1773667907603,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.rmed.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T17:54:36Z","timestamp":1462384476000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation"],"prefix":"10.1016","volume":"119","author":[{"given":"Andrea","family":"Arf\u00e8","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2285-9970","authenticated-orcid":false,"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Merlino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2016.05.004_bib1","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2015. Available from: www.ginasthma.org."},{"key":"10.1016\/j.rmed.2016.05.004_bib2","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1186\/1471-2466-9-24","article-title":"Economic burden of asthma: a systematic review","volume":"9","author":"Bahadori","year":"2009","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2016.05.004_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1183\/09031936.00061611","article-title":"GEIRD Study Group. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010","volume":"39","author":"de Marco","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2016.05.004_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1398-9995.2007.01523.x","article-title":"Therapy and health economics working group of the European Community Respiratory Health Survey II. The socio-economic burden of asthma is substantial in Europe","volume":"63","author":"Accordini","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2016.05.004_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(98)06128-5","article-title":"Differences between asthma exacerbations and poor asthma control [erratum in Lancet 1999; 353:758]","volume":"353","author":"Reddel","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2016.05.004_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(03)12891-7","article-title":"START Investigators Group. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial","volume":"361","author":"Pauwels","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2016.05.004_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s13054-014-0471-7","article-title":"Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up","volume":"18","author":"Long","year":"2014","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.rmed.2016.05.004_bib8","article-title":"Antibiotics for acute asthma","author":"Graham","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2016.05.004_bib9","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1164\/ajrccm.164.8.2104102","article-title":"Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial","volume":"164","author":"O\u2019Byrne","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2016.05.004_bib10","article-title":"Inhaled beclomethasone versus placebo for chronic asthma","author":"Adams","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2016.05.004_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.coph.2006.11.013","article-title":"Antibiotics for the treatment of asthma","volume":"7","author":"Black","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.rmed.2016.05.004_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00228-013-1615-4","article-title":"Interregional Italian Drug Utilisation Group. Antibiotic and anti-asthmatic drug prescriptions in Italy: geographic patterns and socio-economic determinants at the district level","volume":"70","author":"Piovani","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.rmed.2016.05.004_bib13","first-page":"111","article-title":"Pharmacoepidemiological research and the linking of electronic healthcare databases available in the Italian region of Lombardy","volume":"2","author":"Corrao","year":"2008","journal-title":"Biomed. Stat. Clin. Epidemiol."},{"key":"10.1016\/j.rmed.2016.05.004_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0962280208092346","article-title":"The case-crossover study design in pharmacoepidemiology","volume":"18","author":"Delaney","year":"2009","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.rmed.2016.05.004_bib15","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"10.1016\/j.rmed.2016.05.004_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(80)90363-0","article-title":"The problem of \u2018\u2018protopathic bias\u2019\u2019 in case-control studies","volume":"68","author":"Horwitz","year":"1980","journal-title":"Am. J. Med."},{"key":"10.1016\/j.rmed.2016.05.004_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pds.1360","article-title":"Application of lag-time into exposure definitions to control for protopathic bias","volume":"16","author":"Tamim","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.rmed.2016.05.004_bib18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/EDE.0b013e31821d09cd","article-title":"Future cases as present controls to adjust for exposure trend bias in case-only studies","volume":"22","author":"Wang","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.rmed.2016.05.004_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u201cto whom do the results of this trial apply?\u201d","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2016.05.004_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1161\/CIRCULATIONAHA.107.703579","article-title":"Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies","volume":"118","author":"Nallamothu","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2016.05.004_bib21","article-title":"Early use of inhaled corticosteroids in the emergency department treatment of acute asthma","volume":"12","author":"Edmonds","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2016.05.004_bib22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2006.06.034","article-title":"Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma","volume":"118","author":"Marceau","year":"2006","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.05.004_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1742-1241.2009.02320.x","article-title":"Budesonide\/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials","volume":"64","author":"Edwards","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.rmed.2016.05.004_bib24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaci.2011.12.974","article-title":"The relationship between combination inhaled corticosteroid and long-acting \u03b2-agonist use and severe asthma exacerbations in a diverse population","volume":"129","author":"Wells","year":"2012","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.05.004_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pupt.2014.09.005","article-title":"Macrolide antibiotics for treatment of asthma in adults: a meta-analysis of 18 randomized controlled clinical studies","volume":"31","author":"Tong","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2016.05.004_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002997.pub2","article-title":"Macrolides for chronic asthma","author":"Richeldi","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2016.05.004_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MCP.0000000000000017","article-title":"Is there a role for macrolides in severe asthma?","volume":"20","author":"Brusselle","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2016.05.004_bib28","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/514753","article-title":"Managing antibiotic use \u2013 impact of infection control","volume":"28","author":"Wenzel","year":"1999","journal-title":"Clin. Infect. Dis."},{"issue":"15","key":"10.1016\/j.rmed.2016.05.004_bib29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa044080","article-title":"TELICAST Investigators. The effect of telithromycin in acute exacerbations of asthma","volume":"354","author":"Johnston","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2016.05.004_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1378\/chest.14-1698","article-title":"What is the role of tiotropium in asthma? A systematic review with meta-analysis","volume":"147","author":"Rodrigo","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2016.05.004_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1465-9921-10-89","article-title":"Anti-inflammatory effects of antibacterials on human bronchial epithelial cells","volume":"10","author":"Zimmermann","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2016.05.004_bib32","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/AAC.46.8.2442-2449.2002","article-title":"Protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide","volume":"46","author":"Shalit","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rmed.2016.05.004_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1081-1206(10)60081-6","article-title":"Seasonal patterns in health care use and pharmaceutical claims for asthma prescriptions for preschool- and school-aged children","volume":"102","author":"Van Dole","year":"2009","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2016.05.004_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.114.04858","article-title":"Generating evidence from computerized healthcare utilization databases","volume":"65","author":"Corrao","year":"2015","journal-title":"Hypertension"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116300804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116300804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:34:26Z","timestamp":1760614466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611116300804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"alternative-id":["S0954611116300804"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.05.004","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}